154 related articles for article (PubMed ID: 15284123)
61. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma.
Browne P; Petrosyan K; Hernandez A; Chan JA
Am J Clin Pathol; 2003 Nov; 120(5):767-77. PubMed ID: 14608905
[TBL] [Abstract][Full Text] [Related]
62. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins.
Strubin M; Newell JW; Matthias P
Cell; 1995 Feb; 80(3):497-506. PubMed ID: 7859290
[TBL] [Abstract][Full Text] [Related]
63. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5.
Bertolino E; Reddy K; Medina KL; Parganas E; Ihle J; Singh H
Nat Immunol; 2005 Aug; 6(8):836-43. PubMed ID: 16025120
[TBL] [Abstract][Full Text] [Related]
64. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
Ando T; Nishimura M; Oka Y
Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027
[TBL] [Abstract][Full Text] [Related]
65. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
[TBL] [Abstract][Full Text] [Related]
66. Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation.
Seitz V; Thomas PE; Zimmermann K; Paul U; Ehlers A; Joosten M; Dimitrova L; Lenze D; Sommerfeld A; Oker E; Leser U; Stein H; Hummel M
Haematologica; 2011 Jun; 96(6):863-70. PubMed ID: 21393330
[TBL] [Abstract][Full Text] [Related]
67. 5-Aza-2'-deoxycytidine leads to down-regulation of aberrant p16INK4A RNA transcripts and restores the functional retinoblastoma protein pathway in hepatocellular carcinoma cell lines.
Suh SI; Pyun HY; Cho JW; Baek WK; Park JB; Kwon T; Park JW; Suh MH; Carson DA
Cancer Lett; 2000 Nov; 160(1):81-8. PubMed ID: 11098088
[TBL] [Abstract][Full Text] [Related]
68. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S
Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295
[TBL] [Abstract][Full Text] [Related]
69. The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells.
Hsi LC; Xi X; Wu Y; Lippman SM
Mol Cancer Ther; 2005 Nov; 4(11):1740-6. PubMed ID: 16275995
[TBL] [Abstract][Full Text] [Related]
70. Epigenetic and transcriptional control of the 15-lipoxygenase-1 gene in a Hodgkin lymphoma cell line.
Liu C; Schain F; Han H; Xu D; Andersson-Sand H; Forsell P; Claesson HE; Björkholm M; Sjöberg J
Exp Cell Res; 2012 Feb; 318(3):169-76. PubMed ID: 22094113
[TBL] [Abstract][Full Text] [Related]
71. A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma.
Holling TM; Bergevoet MW; Wilson L; Van Eggermond MC; Schooten E; Steenbergen RD; Snijders PJ; Jager MJ; Van den Elsen PJ
J Immunol; 2007 Oct; 179(8):5317-25. PubMed ID: 17911618
[TBL] [Abstract][Full Text] [Related]
72. Digging deep into "dirty" drugs - modulation of the methylation machinery.
Pleyer L; Greil R
Drug Metab Rev; 2015 May; 47(2):252-79. PubMed ID: 25566693
[TBL] [Abstract][Full Text] [Related]
73. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
Chan DW; Lee JM; Chan PC; Ng IO
Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387
[TBL] [Abstract][Full Text] [Related]
74. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
75. Silencing of CDX2 expression in colon cancer via a dominant repression pathway.
Hinoi T; Loda M; Fearon ER
J Biol Chem; 2003 Nov; 278(45):44608-16. PubMed ID: 12947088
[TBL] [Abstract][Full Text] [Related]
76. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
77. Regulation of the immunoglobulin heavy chain locus expression at the phylogenetic level of a bony fish: transcription factor interaction with two variant octamer motifs.
Hikima J; Lennard ML; Wilson MR; Miller NW; Warr GW
Gene; 2006 Aug; 377():119-29. PubMed ID: 16759823
[TBL] [Abstract][Full Text] [Related]
78. Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Martín-Subero JI; Klapper W; Sotnikova A; Callet-Bauchu E; Harder L; Bastard C; Schmitz R; Grohmann S; Höppner J; Riemke J; Barth TF; Berger F; Bernd HW; Claviez A; Gesk S; Frank GA; Kaplanskaya IB; Möller P; Parwaresch RM; Rüdiger T; Stein H; Küppers R; Hansmann ML; Siebert R;
Cancer Res; 2006 Nov; 66(21):10332-8. PubMed ID: 17079453
[TBL] [Abstract][Full Text] [Related]
79. Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines.
Schweitzer BL; DeKoter RP
J Immunol; 2004 Jan; 172(1):144-54. PubMed ID: 14688320
[TBL] [Abstract][Full Text] [Related]
80. Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy.
Takeshima H; Wakabayashi M; Hattori N; Yamashita S; Ushijima T
Carcinogenesis; 2015 Feb; 36(2):192-201. PubMed ID: 25477340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
